Santa Monica, CA, Dec. 21, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has officially issued a letter to its shareholders […]
Rhythm
Impulse Dynamics’ Optimizer® Receives CFDA Approval in China
ORANGEBURG, New York and STUTTGART, Germany, December 18, 2017 /PRNewswire/ — The China Food and Drug Administration (CFDA) has approved Impulse Dynamics’ Optimizer® system for treatment of chronic heart failure. The announcement was made on December 12, 2017 by Impulse Dynamics’ CEO, Dr. Simos Kedikoglou. “This is a major milestone for Impulse Dynamics, as it will help us […]
FierceMedTech Names Endotronix as one of its “Fierce 15” MedTech Companies of 2017
LISLE, Ill., Dec. 11, 2017 /PRNewswire/ — Endotronix, Inc., a digital health medtech company providing innovative solutions for heart failure management, today announced that it has been named by FierceMedTech as one of 2017’s Fierce 15 MedTech companies, recognizing it as one of the most promising private medical technology companies in the industry. “We are honored […]
AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias
MOUNTAIN VIEW, Calif., Dec. 12, 2017 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (EKG) technology, today announced issuance of a U.S. patent which covers the use of data collected from wearable devices as a means of assisting diagnoses of heart arrhythmias, including those that may be asymptomatic. U.S. Patent […]
Imricor Awarded NIH Contract to Develop MR Compatible Catheter for MRI-Guided Cardiac Procedures
Minneapolis, MN – December 5, 2017 – Imricor Medical Systems announced that it has been awarded a contract for up to $2.4 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to develop an MR compatible injection catheter for MRI-guided procedures. This ten month […]
BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) — BioTelemetry(NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple(NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study. […]
CardioFocus® Completes Successful Controlled U.S. Commercial Launch of the HeartLight® System
MARLBOROUGH, Mass., Nov. 29, 2017 /PRNewswire/ — CardioFocus, Inc. today announced the successful completion of its controlled U.S. commercial launch of the HeartLight® Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF). Ten leading cardiac centers across the country have initiated HeartLight programs. The HeartLight System is a visually guided laser balloon technology for controlled […]
ZOLL and Myant Enter Strategic Research and Development Collaboration
CHELMSFORD, Mass. & TORONTO–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, and Myant, Inc., a high-tech advanced manufacturing company that is pioneering the application of technology and soft electronics into textiles, today announced that they have entered an exclusive strategic multi-year agreement to […]
Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers
DUBLIN – November 20, 2017 – Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology. Available in both single chamber and dual chamber models, the Azure XT MRI and Azure S MRI pacemakers offer improved longevity, estimated at 13.7 […]
LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million
LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]



